Literature DB >> 1281154

The dual role of the cAMP-dependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions.

H Sugiyama1, P Chen, M Hunter, R Taffs, M Sitkovsky.   

Abstract

In order to directly evaluate the role of the cAMP-dependent protein kinase (PKA) catalytic (C) subunit in T-cell receptor- (TCR) triggered cytotoxic T-lymphocytes (CTL) effector functions, cells were studied after pretreatment with antisense oligomers complementary to mRNA for the C alpha or C beta subunits. C alpha subunit is shown to be predominantly expressed in CTL. In some experiments the pretreatment of the CTL with the C alpha antisense, but not with the control or C beta antisense oligomers, resulted in the inhibition of cAMP-independent PKA activity without significantly affecting the level of total cAMP-inducible PKA activity. In parallel assays, CTL which were pretreated with the C alpha antisense oligomer had enhanced antigen-bearing target cell-triggered-, anti-TCR monoclonal antibody-triggered-, and phorbol 12-myristate 13-acetate/A23187-triggered exocytosis of granules, as well as enhanced antigen-specific cytotoxicity. In contrast, the TCR-triggered gamma-interferon mRNA expression and gamma-interferon secretion were inhibited in C alpha antisense-pretreated CTL. These results suggest that the C alpha subunit of PKA may have a dual role in regulation of T-lymphocytes effector functions: (i) it may down-regulate TCR-triggered protein-synthesis independent responses such as cytotoxicity and exocytosis, thereby counteracting TCR-triggered activation even in the absence of the second messenger, cAMP, and (ii) the C alpha subunit activity is likely to be required for the nuclear and/or cytoplasmic events in CTL's activation involved in lymphokine synthesis and secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281154

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Inhibition of T cell cAMP formation by cyclosporin A and FK506.

Authors:  H M Ockenfels; S N Wagner; P Oeljeklaus; B Schneck; G Nussbaum; K H Jakobs; M Goos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

2.  Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2).

Authors:  Jintang Sun; Yan Zhang; Meixiang Yang; Yun Zhang; Qi Xie; Zewu Li; Zhaogang Dong; Yongmei Yang; Biping Deng; Alei Feng; Weixu Hu; Haiting Mao; Xun Qu
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

3.  Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.

Authors:  Yunyun Su; Edwin K Jackson; Elieser Gorelik
Journal:  Cancer Immunol Immunother       Date:  2010-10-20       Impact factor: 6.968

4.  Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.

Authors:  G M Kammer; I U Khan; C J Malemud
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 5.  Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.

Authors:  M Sitkovsky; D Lukashev; S Deaglio; K Dwyer; S C Robson; A Ohta
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

6.  Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.

Authors:  J M Cook-Mills; M B Mokyr; R L Cohen; R L Perlman; D A Chambers
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

7.  From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.

Authors:  Dmitriy Lukashev; Michail Sitkovsky; Akio Ohta
Journal:  Purinergic Signal       Date:  2007-01-24       Impact factor: 3.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.